Form 4 for ATRA Atara Biotherapeutics, Inc.
Accepted 2022-08-18 00:00:00 ET · period of report 2022-08-16 · accession 0001140361-22-030302 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-08-18 | 2022-08-16 | ATRA | Touchon Pascal | Pres, CEO, Dir | S - Sale | $5.04 | -14.8K | 457.3K | -3% | -$74.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-08-16 | S | D | 14,806 | $5.04 | 457,287 | D | — | — | (F2) The sale price of the reporting person's shares represents the weighted average price of all shares sold by a broker on August 16, 2022 on behalf of a group of employees of the Issuer to satisfy the payment of withholding tax liability of such employee. |